About Hound Labs
Flaskworks addresses the challenge of manufacturing personalized, cell-based cancer therapies effectively and affordably. Our bioreactor systems focus on dendritic cell and T cell manufacturing for research and clinical use. Flaskworks was acquired by Northwest Biotherapeutics in September 2020.
